+86 189 1304 2753 product@eynoslifescience.com
Terminally differentiated B cells→CD138⁺ CD38⁺ antibody-secreting cells

Plasma cells are the terminally differentiated product of B cells: surface CD19 falls, CD138 (syndecan-1) and CD38 rise, and the cell becomes an antibody factory. They matter in autoimmune disease, multiple myeloma and vaccine-response studies.

What this covers

Matching products

More in B cells

Protocol 3 of 3 in B cells. The Chinese edition of this page carries the full bench-level detail, including reagent volumes and step timings: Chinese edition.

Need this protocol adapted to your sample?

Tell us your cell type, sample source and downstream assay — we will suggest an isolation route, a culture condition and the matching catalogue numbers.